表紙:ダウン症候群:世界の治験動向(2021年上半期)
市場調査レポート
商品コード
1008855

ダウン症候群:世界の治験動向(2021年上半期)

Down Syndrome - Global Clinical Trials Review, H1, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 87 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.49円
ダウン症候群:世界の治験動向(2021年上半期)
出版日: 2021年05月21日
発行: GlobalData
ページ情報: 英文 87 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、ダウン症候群の治験に関連する基本情報やデータを提供しており、先進7か国(G7)および新興7か国(E7)の試験件数および被験者の募集状況、段階別の動向、治験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

目次

  • レポートガイダンス
  • 調査範囲
  • 各国の治験件数
  • 試験件数と平均被験者数
  • アジア太平洋地域の主要5か国の治験件数
  • 欧州の主要5か国の治験件数
  • 北米の主要国の治験件数
  • 中東・アフリカの主要5ヶ国の治験件数
  • 中南米の主要国の治験件数
  • G7諸国の治験件数:遺伝子疾患治験におけるダウン症候群の割合
  • G7諸国の治験件数:段階別
  • G7諸国の治験件数:治験状況別
  • E7諸国の治験件数:遺伝子疾患におけるダウン症候群の割合
  • E7諸国の治験件数:段階別
  • E7諸国の治験件数:治験状況別
  • 治験件数:段階別
  • 進行中の試験件数:段階別
  • 治験件数:治験状況別
  • 治験件数:エンドポイント状況別
  • 一定期間に募集された被験者数
  • 治験件数:スポンサー種類別
  • 主要スポンサー
  • ダウン症候群治療薬の治験に参加する上位企業
  • 有望な薬品
  • 治験のプロファイル

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • ソース
図表

List of Tables

List of Tables

  • Down Syndrome Therapeutics, Global, Clinical Trials by Region, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2021*
  • Proportion of Down Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Down Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Down Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Down Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Down Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Down Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Down Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
  • Down Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2021*
  • Proportion of Down Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Down Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Down Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Down Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Down Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Down Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Down Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology
目次
Product Code: GDHC6686CTIDB

GlobalData's clinical trial report, "Down Syndrome - Global Clinical Trials Review, H1, 2021" provides an overview of Down Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Down Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Down Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source